A-B secure; large-bore IV, NS bolus if shocked; check K⁺ before insulin; monitor + catheter; treat precipitant.
Diagnosis (2024 Int'l Consensus)
Glucose ≥200 mg/dL (or known diabetes regardless of glucose) + β-hydroxybutyrate (BOHB) ≥3.0 mmol/L — venous/capillary BOHB preferred over urine ketones — + pH <7.30 and/or HCO₃ <18; anion gap only supportive if ketones unavailable; severe = BOHB >6.0 mmol/L
Calculators:
FIRST:Normal saline bolus (fluids) — pH/bicarbonate matter more than glucose
Check K⁺ BEFORE insulin:K <3.3 → replace K first & hold insulin; 3.3–5.2 → add K to fluids; >5.2 → monitor
Start:IV regular insulin continuous drip 0.1 U/kg/h (effect within 30 min; if none → re-bolus NS + insulin)
When glucose <250 mg/dL →add dextrose and reduce infusion to 0.05 U/kg/h; continue until resolution = glucose <200 mg/dL AND venous pH >7.3 AND/OR bicarb ≥18 AND BOHB <0.6 mmol/L — anion gap is no longer a resolution criterion
Bicarbonate:NOT recommended in DKA at any pH (no benefit on resolution, LOS, or outcomes; worsens hypokalemia — 2024 Int'l Consensus, ADA 2026)
Decision tree
K⁺ before insulin?
K⁺ <3.3
Hold insulin; replace K⁺ first
K⁺ 3.3–5.2
Add K⁺ to fluids; start insulin
K⁺ >5.2
Start insulin; monitor, replace K⁺ when it falls
Order set
VBG/ABG
Glucose, serum/POC β-hydroxybutyrate (BOHB — not urine ketones)
Stopping insulin before resolution/basal SC overlap
Bicarbonate routinely
Disposition & follow-up
HDU/ICU if severe; transition to SC insulin when resolved.
Discharge package
MedicationsResume/adjust insulin; sick-day rules
Follow-upDiabetes team review
LifestyleNever omit insulin; ketone monitoring when unwell
Warning symptomsVomiting, high glucose/ketones, drowsiness
💊 Treatment detail — doses & preparation
0.9% Sodium chloridecrystalloid
DoseBolus 500 mL over 15–30 min, reassess; maintenance 1–1.5 mL/kg/h
Preparation500/1000 mL bags; add KCl only after urine output confirmed
MonitorHyperchloraemic acidosis with large volumes — prefer balanced (LR) for resuscitation
Insulin regular IV (Actrapid)DKA infusion
Dose0.1 U/kg/h IV (0.05 if mild); never <1 U/h until acidosis resolves; add early basal insulin 0.15–0.3 U/kg alongside infusion; when glucose <250 mg/dL → add dextrose & reduce to 0.05 U/kg/h; stop only at resolution (BOHB <0.6 + pH >7.3/HCO₃ ≥18 + glucose <200) after basal SC overlap 1–2 h (2–4 h per ADA 2026). Mild uncomplicated DKA: SC rapid-acting insulin q1–2h is an alternative (non-ICU)
Preparation50 units in 50 mL NS (1 U/mL) via syringe pump; prime line (insulin binds plastic)
MonitorGlucose hourly, K⁺ q2–4 h — shift drops K⁺; never stop before ketones cleared
Potassium chlorideelectrolyte
DosePO 40–100 mmol/day divided. IV: 10 mmol/h peripheral, 20 mmol/h central with cardiac monitor
PreparationIV: NEVER undiluted push — 10 mmol in 100 mL or 40 mmol/L bag via pump
MonitorK⁺ q4–6 h during replacement, ECG, urine output >0.5 mL/kg/h
Dextrose 10% infusionhypoglycaemia/ALF
Dose100–200 mL/h of 10% titrated to glucose 5–8 mmol/L
Preparation500 mL/1 L bags; give with thiamine in at-risk patients
MonitorCapillary glucose q1–2 h in liver failure
📖 2024 Int'l DKA Consensus (Umpierrez) + ADA SoC 2026 §16Reviewed July 2026
ICU Decoded — original critical-care and internal-medicine pathways by
Dr Javed Akhtar, each cited to a current guideline. For education and quick
reference; verify every dose against local protocols before prescribing.